Surveillance decision

Surveillance decision

We will not update the guideline on acute kidney injury at this time.

Reason for the decision

Assessing the evidence

We found 109 studies through surveillance of this guideline.

This included evidence on:

  • assessing the risk of acute kidney injury (AKI) in adults

  • preventing AKI in adults having iodinated contrast agents

  • monitoring and preventing deterioration in patients with or at high risk of AKI.

We asked topic experts whether this evidence would affect current recommendations. Generally, the topic experts thought that an update of these areas was not needed.

We also identified evidence that supports current recommendations on:

  • preventing the inappropriate use of nephrotoxic drugs

  • referring for renal replacement therapy (RRT).

We found evidence which was not covered in the guideline on:

  • remote ischemic conditioning to prevent AKI after cardiac surgery

  • pharmacological interventions to prevent AKI after cardiac surgery

  • choice of RRT

  • detection and management of AKI in the community setting.

However, the evidence was insufficient to add new recommendations in these areas at this time.

We did not find any evidence related to early warning scores in children, staging of AKI, urinalysis, ultrasound, relieving urological obstruction, referring to nephrology.


No equalities issues were identified during the surveillance process.

Overall decision

After considering all the evidence and views of topic experts and stakeholders, we decided not to update the guideline at this time.

See how we made the decision for further information.

This page was last updated: 13 April 2017